ID   PGFRB_RAT               Reviewed;        1097 AA.
AC   Q05030; Q8R406; Q925F7;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   25-JUL-2003, sequence version 2.
DT   02-OCT-2024, entry version 202.
DE   RecName: Full=Platelet-derived growth factor receptor beta;
DE            Short=PDGF-R-beta;
DE            Short=PDGFR-beta;
DE            EC=2.7.10.1;
DE   AltName: Full=Beta platelet-derived growth factor receptor;
DE   AltName: Full=Beta-type platelet-derived growth factor receptor;
DE   AltName: Full=CD140 antigen-like family member B;
DE   AltName: Full=Platelet-derived growth factor receptor 1;
DE            Short=PDGFR-1;
DE   AltName: CD_antigen=CD140b;
DE   Flags: Precursor;
GN   Name=Pdgfrb; Synonyms=Pdgfr, Pdgfr1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RA   Wang Y., Culty M.;
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 35-533.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=8318539; DOI=10.1016/0167-4781(93)90127-y;
RA   Herren B., Weyer K.A., Rouge M., Loetscher P., Pech M.;
RT   "Conservation in sequence and affinity of human and rodent PDGF ligands and
RT   receptors.";
RL   Biochim. Biophys. Acta 1173:294-302(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 528-1090.
RC   STRAIN=Wistar;
RX   PubMed=11346654; DOI=10.1074/jbc.m102995200;
RA   Okuyama H., Shimahara Y., Kawada N., Seki S., Kristensen D.B.,
RA   Yoshizato K., Uyama N., Yamaoka Y.;
RT   "Regulation of cell growth by redox-mediated extracellular proteolysis of
RT   platelet-derived growth factor receptor beta.";
RL   J. Biol. Chem. 276:28274-28280(2001).
CC   -!- FUNCTION: Tyrosine-protein kinase that acts as a cell-surface receptor
CC       for homodimeric PDGFB and PDGFD and for heterodimers formed by PDGFA
CC       and PDGFB, and plays an essential role in the regulation of embryonic
CC       development, cell proliferation, survival, differentiation, chemotaxis
CC       and migration. Plays an essential role in blood vessel development by
CC       promoting proliferation, migration and recruitment of pericytes and
CC       smooth muscle cells to endothelial cells. Plays a role in the migration
CC       of vascular smooth muscle cells and the formation of neointima at
CC       vascular injury sites. Required for normal development of the
CC       cardiovascular system. Required for normal recruitment of pericytes
CC       (mesangial cells) in the kidney glomerulus, and for normal formation of
CC       a branched network of capillaries in kidney glomeruli. Promotes
CC       rearrangement of the actin cytoskeleton and the formation of membrane
CC       ruffles. Binding of its cognate ligands - homodimeric PDGFB,
CC       heterodimers formed by PDGFA and PDGFB or homodimeric PDGFD -leads to
CC       the activation of several signaling cascades; the response depends on
CC       the nature of the bound ligand and is modulated by the formation of
CC       heterodimers between PDGFRA and PDGFRB. Phosphorylates PLCG1, PIK3R1,
CC       PTPN11, RASA1/GAP, CBL, SHC1 and NCK1. Activation of PLCG1 leads to the
CC       production of the cellular signaling molecules diacylglycerol and
CC       inositol 1,4,5-trisphosphate, mobilization of cytosolic Ca(2+) and the
CC       activation of protein kinase C. Phosphorylation of PIK3R1, the
CC       regulatory subunit of phosphatidylinositol 3-kinase, leads to the
CC       activation of the AKT1 signaling pathway. Phosphorylation of SHC1, or
CC       of the C-terminus of PTPN11, creates a binding site for GRB2, resulting
CC       in the activation of HRAS, RAF1 and down-stream MAP kinases, including
CC       MAPK1/ERK2 and/or MAPK3/ERK1. Promotes phosphorylation and activation
CC       of SRC family kinases. Promotes phosphorylation of PDCD6IP/ALIX and
CC       STAM. Receptor signaling is down-regulated by protein phosphatases that
CC       dephosphorylate the receptor and its down-stream effectors, and by
CC       rapid internalization of the activated receptor (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- ACTIVITY REGULATION: Present in an inactive conformation in the absence
CC       of bound ligand. Binding of PDGFB and/or PDGFD leads to dimerization
CC       and activation by autophosphorylation on tyrosine residues (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with homodimeric PDGFB and PDGFD, and with
CC       heterodimers formed by PDGFA and PDGFB. May also interact with
CC       homodimeric PDGFC. Monomer in the absence of bound ligand. Interaction
CC       with homodimeric PDGFB, heterodimers formed by PDGFA and PDGFB or
CC       homodimeric PDGFD, leads to receptor dimerization, where both PDGFRA
CC       homodimers and heterodimers with PDGFRB are observed. Interacts with
CC       SH2B2/APS. Interacts directly (tyrosine phosphorylated) with SHB.
CC       Interacts (tyrosine phosphorylated) with PIK3R1 and RASA1. Interacts
CC       (tyrosine phosphorylated) with CBL. Interacts (tyrosine phosphorylated)
CC       with SRC and SRC family kinases. Interacts (tyrosine phosphorylated)
CC       with PIK3C2B, maybe indirectly. Interacts (tyrosine phosphorylated)
CC       with SHC1, GRB7, GRB10 and NCK1. Interaction with GRB2 is mediated by
CC       SHC1. Interacts (via C-terminus) with NHERF1 (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I
CC       membrane protein {ECO:0000250}. Cytoplasmic vesicle {ECO:0000250}.
CC       Lysosome lumen {ECO:0000250}. Note=After ligand binding, the
CC       autophosphorylated receptor is ubiquitinated and internalized, leading
CC       to its degradation. {ECO:0000250}.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- PTM: Ubiquitinated. After autophosphorylation, the receptor is
CC       polyubiquitinated, leading to its degradation (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Autophosphorylated on tyrosine residues upon ligand binding.
CC       Autophosphorylation occurs in trans, i.e. one subunit of the dimeric
CC       receptor phosphorylates tyrosine residues on the other subunit.
CC       Phosphorylation at Tyr-578, and to a lesser degree, Tyr-580 is
CC       important for interaction with SRC. Phosphorylation at Tyr-715 is
CC       important for interaction with GRB2. Phosphorylation at Tyr-739 and
CC       Tyr-750 is important for interaction with PIK3R1. Phosphorylation at
CC       Tyr-750 is important for interaction with NCK1. Phosphorylation at Tyr-
CC       770 and Tyr-856 is important for interaction with RASA1/GAP.
CC       Phosphorylation at Tyr-856 is important for efficient phosphorylation
CC       of PLCG1 and PTPN11, resulting in increased phosphorylation of AKT1,
CC       MAPK1/ERK2 and/or MAPK3/ERK1, PDCD6IP/ALIX and STAM, and in increased
CC       cell proliferation. Phosphorylation at Tyr-1008 is important for
CC       interaction with PTPN11. Phosphorylation at Tyr-1008 and Tyr-1020 is
CC       important for interaction with PLCG1. Dephosphorylated by PTPRJ at Tyr-
CC       750, Tyr-856, Tyr-1008 and Tyr-1020. Dephosphorylated by PTPN2 at Tyr-
CC       578 and Tyr-1020 (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. CSF-1/PDGF receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY090783; AAM09098.1; -; mRNA.
DR   EMBL; Z14119; CAA78489.1; -; mRNA.
DR   EMBL; AF359356; AAK43716.1; -; mRNA.
DR   PIR; S33766; S33766.
DR   RefSeq; NP_113713.1; NM_031525.1.
DR   RefSeq; XP_006254851.1; XM_006254789.3.
DR   AlphaFoldDB; Q05030; -.
DR   SMR; Q05030; -.
DR   BioGRID; 246767; 2.
DR   IntAct; Q05030; 2.
DR   MINT; Q05030; -.
DR   STRING; 10116.ENSRNOP00000060534; -.
DR   BindingDB; Q05030; -.
DR   ChEMBL; CHEMBL4125; -.
DR   DrugCentral; Q05030; -.
DR   GlyCosmos; Q05030; 11 sites, No reported glycans.
DR   GlyGen; Q05030; 11 sites.
DR   iPTMnet; Q05030; -.
DR   PhosphoSitePlus; Q05030; -.
DR   jPOST; Q05030; -.
DR   PaxDb; 10116-ENSRNOP00000060534; -.
DR   ABCD; Q05030; 1 sequenced antibody.
DR   GeneID; 24629; -.
DR   KEGG; rno:24629; -.
DR   UCSC; RGD:3285; rat.
DR   AGR; RGD:3285; -.
DR   CTD; 5159; -.
DR   RGD; 3285; Pdgfrb.
DR   VEuPathDB; HostDB:ENSRNOG00000018461; -.
DR   eggNOG; KOG0200; Eukaryota.
DR   HOGENOM; CLU_000288_49_0_1; -.
DR   InParanoid; Q05030; -.
DR   OrthoDB; 1614410at2759; -.
DR   PhylomeDB; Q05030; -.
DR   Reactome; R-RNO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-RNO-186763; Downstream signal transduction.
DR   Reactome; R-RNO-186797; Signaling by PDGF.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   PRO; PR:Q05030; -.
DR   Proteomes; UP000002494; Chromosome 18.
DR   Bgee; ENSRNOG00000018461; Expressed in ovary and 18 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW.
DR   GO; GO:0043202; C:lysosomal lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0001726; C:ruffle; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0016301; F:kinase activity; ISO:RGD.
DR   GO; GO:0043548; F:phosphatidylinositol 3-kinase binding; IPI:RGD.
DR   GO; GO:0005019; F:platelet-derived growth factor beta-receptor activity; ISS:UniProtKB.
DR   GO; GO:0048407; F:platelet-derived growth factor binding; ISO:RGD.
DR   GO; GO:0005017; F:platelet-derived growth factor receptor activity; IDA:RGD.
DR   GO; GO:0005161; F:platelet-derived growth factor receptor binding; ISO:RGD.
DR   GO; GO:0004672; F:protein kinase activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0038085; F:vascular endothelial growth factor binding; ISO:RGD.
DR   GO; GO:0030325; P:adrenal gland development; ISO:RGD.
DR   GO; GO:0035909; P:aorta morphogenesis; ISO:RGD.
DR   GO; GO:0001568; P:blood vessel development; ISO:RGD.
DR   GO; GO:0055003; P:cardiac myofibril assembly; ISS:UniProtKB.
DR   GO; GO:0060326; P:cell chemotaxis; ISS:UniProtKB.
DR   GO; GO:0060981; P:cell migration involved in coronary angiogenesis; ISS:UniProtKB.
DR   GO; GO:0035441; P:cell migration involved in vasculogenesis; ISS:UniProtKB.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; ISO:RGD.
DR   GO; GO:0048568; P:embryonic organ development; ISO:RGD.
DR   GO; GO:0006024; P:glycosaminoglycan biosynthetic process; IMP:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0048839; P:inner ear development; IEP:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IMP:RGD.
DR   GO; GO:0001822; P:kidney development; ISO:RGD.
DR   GO; GO:0060437; P:lung growth; IMP:RGD.
DR   GO; GO:0008584; P:male gonad development; IEP:RGD.
DR   GO; GO:0072278; P:metanephric comma-shaped body morphogenesis; IEP:UniProtKB.
DR   GO; GO:0072277; P:metanephric glomerular capillary formation; ISS:UniProtKB.
DR   GO; GO:0072262; P:metanephric glomerular mesangial cell proliferation involved in metanephros development; ISS:UniProtKB.
DR   GO; GO:0072223; P:metanephric glomerular mesangium development; ISO:RGD.
DR   GO; GO:0072275; P:metanephric glomerulus morphogenesis; IEP:UniProtKB.
DR   GO; GO:0035789; P:metanephric mesenchymal cell migration; IDA:UniProtKB.
DR   GO; GO:0072075; P:metanephric mesenchyme development; IEP:UniProtKB.
DR   GO; GO:0072284; P:metanephric S-shaped body morphogenesis; IEP:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0046488; P:phosphatidylinositol metabolic process; ISS:UniProtKB.
DR   GO; GO:0048008; P:platelet-derived growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0035791; P:platelet-derived growth factor receptor-beta signaling pathway; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0090280; P:positive regulation of calcium ion import; ISS:UniProtKB.
DR   GO; GO:0050850; P:positive regulation of calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0038091; P:positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0050921; P:positive regulation of chemotaxis; ISS:UniProtKB.
DR   GO; GO:0032967; P:positive regulation of collagen biosynthetic process; IMP:RGD.
DR   GO; GO:2000573; P:positive regulation of DNA biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; IMP:RGD.
DR   GO; GO:2000491; P:positive regulation of hepatic stellate cell activation; IMP:RGD.
DR   GO; GO:0043406; P:positive regulation of MAP kinase activity; ISS:UniProtKB.
DR   GO; GO:0035793; P:positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway; ISS:UniProtKB.
DR   GO; GO:0045840; P:positive regulation of mitotic nuclear division; ISS:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISS:UniProtKB.
DR   GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; ISS:UniProtKB.
DR   GO; GO:0035025; P:positive regulation of Rho protein signal transduction; IMP:RGD.
DR   GO; GO:0014911; P:positive regulation of smooth muscle cell migration; ISS:UniProtKB.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0106096; P:response to ceramide; ISO:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0043627; P:response to estrogen; IEP:RGD.
DR   GO; GO:0034405; P:response to fluid shear stress; IEP:RGD.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0055093; P:response to hyperoxia; IEP:RGD.
DR   GO; GO:0033993; P:response to lipid; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0032526; P:response to retinoic acid; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   GO; GO:0061298; P:retina vasculature development in camera-type eye; ISS:UniProtKB.
DR   GO; GO:0097178; P:ruffle assembly; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0048705; P:skeletal system morphogenesis; ISO:RGD.
DR   GO; GO:0071670; P:smooth muscle cell chemotaxis; ISO:RGD.
DR   GO; GO:0048745; P:smooth muscle tissue development; ISO:RGD.
DR   GO; GO:0001894; P:tissue homeostasis; ISO:RGD.
DR   CDD; cd00096; Ig; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 5.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013151; Immunoglobulin_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR027288; PGFRB.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR050122; RTK.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR001824; Tyr_kinase_rcpt_3_CS.
DR   PANTHER; PTHR24416:SF53; PLATELET-DERIVED GROWTH FACTOR RECEPTOR BETA; 1.
DR   PANTHER; PTHR24416; TYROSINE-PROTEIN KINASE RECEPTOR; 1.
DR   Pfam; PF00047; ig; 1.
DR   Pfam; PF13927; Ig_3; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PIRSF; PIRSF500948; Beta-PDGF_receptor; 1.
DR   PIRSF; PIRSF000615; TyrPK_CSF1-R; 1.
DR   PRINTS; PR01832; VEGFRECEPTOR.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 4.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00240; RECEPTOR_TYR_KIN_III; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Cell membrane; Chemotaxis; Cytoplasmic vesicle;
KW   Developmental protein; Disulfide bond; Glycoprotein; Immunoglobulin domain;
KW   Kinase; Lysosome; Membrane; Nucleotide-binding; Phosphoprotein; Receptor;
KW   Reference proteome; Repeat; Signal; Transferase; Transmembrane;
KW   Transmembrane helix; Tyrosine-protein kinase; Ubl conjugation.
FT   SIGNAL          1..31
FT                   /evidence="ECO:0000255"
FT   CHAIN           32..1097
FT                   /note="Platelet-derived growth factor receptor beta"
FT                   /id="PRO_0000016759"
FT   TOPO_DOM        32..531
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        532..552
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        553..1097
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          32..119
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          128..209
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          213..308
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          415..523
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          599..961
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1016..1097
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1040..1063
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        825
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         605..613
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         633
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         561
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09619"
FT   MOD_RES         578
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09619"
FT   MOD_RES         580
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09619"
FT   MOD_RES         685
FT                   /note="Phosphotyrosine; by ABL1 and ABL2"
FT                   /evidence="ECO:0000250|UniProtKB:P05622"
FT   MOD_RES         715
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09619"
FT   MOD_RES         739
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09619"
FT   MOD_RES         750
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09619"
FT   MOD_RES         762
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09619"
FT   MOD_RES         770
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09619"
FT   MOD_RES         774
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09619"
FT   MOD_RES         777
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09619"
FT   MOD_RES         856
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09619"
FT   MOD_RES         933
FT                   /note="Phosphotyrosine; by ABL1 and ABL2"
FT                   /evidence="ECO:0000250|UniProtKB:P05622"
FT   MOD_RES         969
FT                   /note="Phosphotyrosine; by ABL1 and ABL2"
FT                   /evidence="ECO:0000250|UniProtKB:P05622"
FT   MOD_RES         1008
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09619"
FT   MOD_RES         1020
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09619"
FT   CARBOHYD        44
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        88
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        102
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        214
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        291
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        306
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        353
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        370
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        444
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        467
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        478
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        53..99
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        148..189
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        234..290
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        435..507
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
SQ   SEQUENCE   1097 AA;  122828 MW;  5E6540FA0C5CF22B CRC64;
     MGLPEVMPAS VLRGQLLLFV LLLLGPQISQ GLVITPPGPE FVLNISSTFV LTCSSSAPVM
     WEQMSQVPWQ EAAMNQDGTF SSVLTLTNVT GGDTGEYFCV YNNSLGPELS ERKRIYIFVP
     DPTMGFLPMD SEDLFIFVTD VTETTIPCRV TDPQLEVTLH EKKVDIPLHV PYDHQRGFIG
     TFEDKTYICK TTIGDREVDS DTYYVYSLQV SSINVSVNAV QTVVRQGESI TIRCIVMGND
     VVNFQWTYPR MKSGRLVEPV TDYLFGVPSR IGSILHIPTA ELSDSGTYTC NVSVSVNDHG
     DEKAINVTVI ENGYVRLLET LEDVQIAELH RSRTLQVVFE AYPTPSVLWF KDNRTLGDSS
     AGELVLSTRN VSETRYVSEL TLVRVKVSEA GYYTMRAFHA DDQVQLSFKL QVNVPVRVLE
     LSESHPANGE QILRCRGRGM PQPNVTWSTC RDLKRCPRKL SPTPLGNSSK EESQLETNVT
     FWEEDQEYEV VSTLRLRHVD QPLSVRCMLQ NSMGRDSQEV TVVPHSLPFK VVVISAILAL
     VVLTVISLII LIMLWQRKPR YEIRWKVIES VSSDGHEYIY VDPVQLPYDS TWELPRDQLV
     LGRTLGSGAF GQVVEATAHG LSHSQATMKV AVKMLKSTAR SSEKQALMSE LKIMSHLGPH
     LNVVNLLGAC TKGGPIYIIT EYCRYGDLVD YLHRNKHTFL QRHSNKHCPP STELYSNALP
     VGLSLPSHLN LTGESDGGYM DMSKDESVDY VPMLDMKGHI KYADIESSSY MAPYDNYVPS
     APERTYRATL INDSPVLSYT DLVGFSYQVA NGMEFLASKN CVHRDLAARN VLICEGKLVK
     ICDFGLARDI MRDSNYISKG STFLPLKWMA PESIFNSLYT TLSDVWSFGI LLWEIFTLGG
     TPYPELPMND QFYNAIKRGY RMAQPAHASD EIYEIMQKCW EEKFETRPPF SQLVLLLERL
     LGEGYKKKYQ QVDEEFLRSD HPAILRSQAR LPGLHSLRSP LDTSSVLYTA VQPNETDNDY
     IIPLPDPKPD AADEGLLEGS PSLASSTLNE VNTSSTISCD SPLELQEEPQ AEPEAQLEQP
     QDSGCPGPLA EAEDSFL
//
